These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3497153)

  • 1. Synergy of clavulanic acid with benzylpenicillin or cephalothin against Yersinia spp.
    Jimenez-Valera M; Ruiz-Bravo A; Ramos-Cormenzana A
    J Antimicrob Chemother; 1987 Jun; 19(6):845-7. PubMed ID: 3497153
    [No Abstract]   [Full Text] [Related]  

  • 2. Synergistic effects of dicloxacillin or clavulanic acid in combination with penicillin G or cephalothin against Yersinia enterocolitica.
    Jimenez-Valera M; Ruiz-Bravo A; Ramos-Cormenzana A
    Antimicrob Agents Chemother; 1986 Jan; 29(1):104-6. PubMed ID: 3488014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation effect of clavulanic acid with penicillin, cephalothin and ticarcillin against Bacteroides fragilis.
    Bansal MB; Chuah SK; Oryema-Lalobo M; Thadepalli H
    Chemotherapy; 1985; 31(3):173-7. PubMed ID: 3996086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative in vitro inhibitory activities of novel beta-lactam compounds against multiresistant beta-lactamase producing Staphylococcus aureus.
    Ray B; Panja K; Bal M
    Indian J Med Res; 1986 May; 83():453-7. PubMed ID: 3015791
    [No Abstract]   [Full Text] [Related]  

  • 5. Bacteriological investigations with beta-lactamase inhibitors.
    Ullmann U
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):222-9. PubMed ID: 6289565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of clavulanic acid, sulbactam and tazobactam (YTR 830) with amoxycillin against fifty beta-lactamase-producing strains of Haemophilus influenzae.
    Simonet M; Moittie D; Philippon A; Descamps P; Veron M
    J Antimicrob Chemother; 1989 May; 23(5):798-800. PubMed ID: 2547748
    [No Abstract]   [Full Text] [Related]  

  • 7. Susceptibility of Yersinia enterocolitica to eight beta-lactam antibiotics and clavulanic acid.
    Gaspar MC; Soriano F
    J Antimicrob Chemother; 1981 Aug; 8(2):161-4. PubMed ID: 7275884
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemistry and action of clavulanic acid.
    Cole M
    Scott Med J; 1982; 27 Spec No.():S10-6. PubMed ID: 6762660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic interaction of amoxycillin and clavulanic acid against 132 beta-lactamase positive Haemophilus isolates: a comparison with some other oral agents.
    Lapointe JR; Lavallée C
    J Antimicrob Chemother; 1987 Jan; 19(1):49-58. PubMed ID: 3494009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.
    Philippon A; Riou JY; Guibourdenche M; Sotolongo F
    Drugs; 1986; 31 Suppl 3():64-9. PubMed ID: 3015547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibacterial activities of amoxicillin alone and in combination with clavulanic acid correlated with beta-lactamase production.
    Hsu LY; Chang SC; Luh KT; Hsieh WC
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1991 Aug; 24(3):272-80. PubMed ID: 1818798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the combination of clavulanic acid and cephalothin on an experimental infection with Yersinia enterocolitica in iron-overloaded mice.
    Jimenez-Valera M; Ruiz-Bravo A; Gómez MC; Ramos-Cormenzana A
    J Antimicrob Chemother; 1988 Nov; 22(5):707-13. PubMed ID: 3209528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in the potentiation of beta-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteria.
    Aldridge KE; Sanders CV; Marier RL
    J Antimicrob Chemother; 1986 Apr; 17(4):463-9. PubMed ID: 3011724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sulbactam and clavulanic acid: studies of enzyme kinetics and synergism with ampicillin and mezlocillin].
    Cullmann W; Binder S; Stieglitz M
    Immun Infekt; 1987 May; 15(3):103-9. PubMed ID: 3038733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and beta-lactamase inhibitory activity of 9-(2-amidoethenylthio)-9-deoxy derivatives of clavulanic acid.
    Brooks G; Coleman K; Davies JS; Hunter PA
    J Antibiot (Tokyo); 1988 Jul; 41(7):892-8. PubMed ID: 3262103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin/tazobactam and ticarcillin/clavulanic acid against resistant Enterobacteriaceae.
    Kempers J; MacLaren DM
    J Antimicrob Chemother; 1990 Oct; 26(4):598-9. PubMed ID: 2174855
    [No Abstract]   [Full Text] [Related]  

  • 17. Clavulanic acid-potentiated activity of amoxicillin against Bacteroides fragilis.
    Indiveri MC; Hirsh DC
    Am J Vet Res; 1985 Oct; 46(10):2207-9. PubMed ID: 4062030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in susceptibility to benzylpenicillin between Yersinia enterocolitica and Yersinia pseudotuberculosis.
    Kanazawa Y; Kuramata T
    Jpn J Microbiol; 1974 Nov; 18(6):483-5. PubMed ID: 4453026
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the beta-lactamase inhibitor clavulanic acid in the isolation of auxotrophic mutants of Bacillus licheniformis.
    Fields PI; Schreier HJ; Saha AL; Bernlohr RW
    J Bacteriol; 1984 Aug; 159(2):803-4. PubMed ID: 6086590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The development of bacterial resistance and the role of clavulanic acid].
    Rolinson JN
    Antibiot Khimioter; 1992 Sep; 37(9):11-4. PubMed ID: 1444658
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.